Both SMBG and CGM are recommended for individuals on intensive insulin regimens (including adults and youth with type 1 diabetes) by the American Association of Clinical Endocrinology Clinical Practice Guideline (2021) and the American Diabetes Association Standards of Medical Care in Diabetes (2020) [4,5]. This evidence concerns the gene INS and diabetes mellitus.